{
    "title": "Dental adverse effects of sublingual buprenorphine and naloxone.",
    "doc_id": "37353308",
    "writer": "[No authors listed]",
    "year": "2023",
    "summary": "",
    "abstract": "Overview of: Etminan M, Rezaeianzadeh R, Kezouh A, et al. Association between sublingual buprenorphine-naloxone exposure and dental disease. JAMA. 2022;328:2269-71.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/37353308/"
}